AU2019319953B2 - Use of inhaled nitric oxide (INO) for the improvement of severe hypoxemia - Google Patents

Use of inhaled nitric oxide (INO) for the improvement of severe hypoxemia Download PDF

Info

Publication number
AU2019319953B2
AU2019319953B2 AU2019319953A AU2019319953A AU2019319953B2 AU 2019319953 B2 AU2019319953 B2 AU 2019319953B2 AU 2019319953 A AU2019319953 A AU 2019319953A AU 2019319953 A AU2019319953 A AU 2019319953A AU 2019319953 B2 AU2019319953 B2 AU 2019319953B2
Authority
AU
Australia
Prior art keywords
patient
nitric oxide
breath
inhaled nitric
delivered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2019319953A
Other languages
English (en)
Other versions
AU2019319953A1 (en
Inventor
Deborah Quinn
Parag Shah
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mallinckrodt Pharmaceuticals Ireland Ltd
Original Assignee
Mallinckrodt Pharmaceuticals Ireland Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Pharmaceuticals Ireland Ltd filed Critical Mallinckrodt Pharmaceuticals Ireland Ltd
Publication of AU2019319953A1 publication Critical patent/AU2019319953A1/en
Application granted granted Critical
Publication of AU2019319953B2 publication Critical patent/AU2019319953B2/en
Assigned to BELLEROPHON THERAPEUTICS, INC. reassignment BELLEROPHON THERAPEUTICS, INC. Amend patent request/document other than specification (104) Assignors: BELLEROPHON THERAPEUTICS
Priority to AU2025203477A priority Critical patent/AU2025203477A1/en
Assigned to MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED reassignment MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED Request for Assignment Assignors: BELLEROPHON THERAPEUTICS, INC.
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/021—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes operated by electrical means
    • A61M16/022—Control means therefor
    • A61M16/024—Control means therefor including calculation means, e.g. using a processor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/08—Measuring devices for evaluating the respiratory organs
    • A61B5/0816—Measuring devices for examining respiratory frequency
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/08—Inhaling devices inserted into the nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/06—Respiratory or anaesthetic masks
    • A61M16/0666—Nasal cannulas or tubing
    • A61M16/0672—Nasal cannula assemblies for oxygen therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/10—Preparation of respiratory gases or vapours
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/10—Preparation of respiratory gases or vapours
    • A61M16/1005—Preparation of respiratory gases or vapours with O2 features or with parameter measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/10—Preparation of respiratory gases or vapours
    • A61M16/12—Preparation of respiratory gases or vapours by mixing different gases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/0003—Accessories therefor, e.g. sensors, vibrators, negative pressure
    • A61M2016/0015—Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors
    • A61M2016/0018—Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors electrical
    • A61M2016/0021—Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors electrical with a proportional output signal, e.g. from a thermistor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/02—Gases
    • A61M2202/0208—Oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/02—Gases
    • A61M2202/0266—Nitrogen (N)
    • A61M2202/0275—Nitric oxide [NO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/20—Blood composition characteristics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/20—Blood composition characteristics
    • A61M2230/205—Blood composition characteristics partial oxygen pressure (P-O2)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Pathology (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Oncology (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2019319953A 2018-08-10 2019-08-08 Use of inhaled nitric oxide (INO) for the improvement of severe hypoxemia Active AU2019319953B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2025203477A AU2025203477A1 (en) 2018-08-10 2025-05-14 Use of inhaled nitric oxide (iNO) for the improvement of severe hypoxemia

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862717433P 2018-08-10 2018-08-10
US62/717,433 2018-08-10
PCT/US2019/045806 WO2020033768A1 (en) 2018-08-10 2019-08-08 Use of inhaled nitric oxide (ino) for the improvement of severe hypoxemia

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2025203477A Division AU2025203477A1 (en) 2018-08-10 2025-05-14 Use of inhaled nitric oxide (iNO) for the improvement of severe hypoxemia

Publications (2)

Publication Number Publication Date
AU2019319953A1 AU2019319953A1 (en) 2021-03-11
AU2019319953B2 true AU2019319953B2 (en) 2025-02-27

Family

ID=69415166

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2019319953A Active AU2019319953B2 (en) 2018-08-10 2019-08-08 Use of inhaled nitric oxide (INO) for the improvement of severe hypoxemia
AU2025203477A Pending AU2025203477A1 (en) 2018-08-10 2025-05-14 Use of inhaled nitric oxide (iNO) for the improvement of severe hypoxemia

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2025203477A Pending AU2025203477A1 (en) 2018-08-10 2025-05-14 Use of inhaled nitric oxide (iNO) for the improvement of severe hypoxemia

Country Status (11)

Country Link
US (1) US20230158260A1 (cg-RX-API-DMAC7.html)
EP (1) EP3833418A4 (cg-RX-API-DMAC7.html)
JP (1) JP2021533866A (cg-RX-API-DMAC7.html)
CN (1) CN112969491A (cg-RX-API-DMAC7.html)
AR (1) AR117632A1 (cg-RX-API-DMAC7.html)
AU (2) AU2019319953B2 (cg-RX-API-DMAC7.html)
CA (1) CA3108273A1 (cg-RX-API-DMAC7.html)
IL (1) IL280444A (cg-RX-API-DMAC7.html)
MX (3) MX2021001430A (cg-RX-API-DMAC7.html)
TW (1) TW202021637A (cg-RX-API-DMAC7.html)
WO (1) WO2020033768A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2019009931A (es) 2017-02-27 2020-07-14 Third Pole Inc Sistemas y metodos para generacion ambulatoria de oxido nitrico.
JP6704094B2 (ja) 2017-02-27 2020-06-03 サード ポール, インコーポレイテッドThird Pole, Inc. 酸化窒素を生成するためのシステムおよび方法
MX2020010523A (es) 2017-02-27 2021-02-09 Third Pole Inc Sistemas y metodos para generar oxido nitrico.
WO2020232414A1 (en) 2019-05-15 2020-11-19 Third Pole, Inc. Architectures for production of nitric oxide
WO2020232419A1 (en) 2019-05-15 2020-11-19 Third Pole, Inc. Systems and methods for generating nitric oxide
EP3969415A4 (en) 2019-05-15 2023-08-16 Third Pole, Inc. ELECTRODES FOR GENERATING NITROUS OXIDE
EP4069069A4 (en) 2020-01-11 2024-07-03 Third Pole, Inc. SYSTEMS AND METHODS FOR NITROGEN OXIDE PRODUCTION WITH HUMIDITY CONTROL
AU2021281427A1 (en) * 2020-05-29 2023-02-02 Mallinckrodt Pharmaceuticals Ireland Limited Method for pulsatile delivery of a gaseous drug
EP4167920A4 (en) 2020-06-18 2024-06-12 Third Pole, Inc. Systems and methods for preventing and treating infections with nitric oxide
WO2022082072A1 (en) 2020-10-16 2022-04-21 Third Pole, Inc. Nitric oxide generation process controls
WO2023049873A1 (en) 2021-09-23 2023-03-30 Third Pole, Inc. Systems and methods for delivering nitric oxide
US12569628B2 (en) 2022-04-14 2026-03-10 Third Pole, Inc. Delivery of medicinal gas in a liquid medium

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120093948A1 (en) * 2009-11-20 2012-04-19 Fine David H Nitric Oxide Treatments

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5890490A (en) * 1996-11-29 1999-04-06 Aylsworth; Alonzo C. Therapeutic gas flow monitoring system
US20060201504A1 (en) * 2005-03-08 2006-09-14 Singhal Aneesh B High-flow oxygen delivery system and methods of use thereof
US7523752B2 (en) 2005-09-21 2009-04-28 Ino Therapeutics, Llc System and method of administering a pharmaceutical gas to a patient
US20080078392A1 (en) * 2006-09-29 2008-04-03 Pelletier Dana G Breath detection system
US8020558B2 (en) * 2007-01-26 2011-09-20 Cs Medical, Inc. System for providing flow-targeted ventilation synchronized to a patient's breathing cycle
SI3498328T1 (sl) 2009-05-27 2021-03-31 Mallinckrodt Hospital Products IP Limited Pripomoček za spajanje indeksiranega ventila in sestava posode pod tlakom s pritrdilnim obročem in za linearno sprožitev sestava sprožilnika pri odvajanju tekočin s pripomočkom za reguliranje dovajanja zdravila
JP5995724B2 (ja) * 2009-11-20 2016-09-21 ゲノ エルエルシー 一酸化窒素送達システム
CN102948078A (zh) 2010-04-23 2013-02-27 Pr电子公司 德尔塔-西格玛调制器
CN104411317A (zh) 2012-03-15 2015-03-11 Ino治疗有限责任公司 用于施用高浓度一氧化碳的方法
CA2892398C (en) 2012-12-04 2023-02-14 Ino Therapeutics Llc Cannula for minimizing dilution of dosing during nitric oxide delivery
MX375330B (es) * 2013-03-13 2025-03-06 Mallinckrodt Hospital Products Ip Ltd Dispositivos y metodos para monitorizar la oxigenacion durante el tratamiento con el suminitro de oxido nitrico.
EP3756714B1 (en) * 2013-03-15 2023-05-17 Mallinckrodt Hospital Products IP Limited Therapeutic gas delivery device with pulsed and continuous flow control
US10758703B2 (en) 2014-10-17 2020-09-01 Mallinckrodt Hospital Products IP Limited Systems and methods for providing a pulse of a therapeutic gas with a desired flow profile to maximize therapeutic effectiveness
US10039781B2 (en) * 2015-03-24 2018-08-07 Ait Therapeutics, Inc. Pulse inhalation of nitric oxide for treating respiratory diseases
US20170165294A1 (en) * 2015-12-11 2017-06-15 Geno Llc Method and apparatus for administering gases including nitric oxide to address fibrosis
PT3970730T (pt) * 2016-02-12 2024-07-30 Mallinckrodt Pharmaceuticals Ireland Ltd Sistema para utilização e monitorização de óxido nítrico inalado com dispositivos de ajuda ventricular esquerda
MX2020006741A (es) * 2017-12-28 2020-11-24 Bellerophon Pulse Tech Llc Uso de oxigeno y oxido nitrico inhalado para el tratamiento de la hipertension pulmonar.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120093948A1 (en) * 2009-11-20 2012-04-19 Fine David H Nitric Oxide Treatments

Also Published As

Publication number Publication date
MX2021001430A (es) 2021-05-12
CA3108273A1 (en) 2020-02-13
AR117632A1 (es) 2021-08-18
AU2025203477A1 (en) 2025-05-29
MX2025006329A (es) 2025-07-01
US20230158260A1 (en) 2023-05-25
JP2021533866A (ja) 2021-12-09
TW202021637A (zh) 2020-06-16
WO2020033768A1 (en) 2020-02-13
CN112969491A (zh) 2021-06-15
AU2019319953A1 (en) 2021-03-11
EP3833418A1 (en) 2021-06-16
EP3833418A4 (en) 2022-08-10
IL280444A (en) 2021-03-25
MX2025003262A (es) 2025-05-02

Similar Documents

Publication Publication Date Title
AU2024219613B2 (en) Method and apparatus for pulsatile delivery of nitric oxide
AU2025203477A1 (en) Use of inhaled nitric oxide (iNO) for the improvement of severe hypoxemia
JP7813138B2 (ja) 肺に関連する状態を有する患者における活動レベルを改善するための一酸化窒素吸入療法(iNO)の使用
US20230067942A1 (en) IMPROVEMENT IN PULMONARY ARTERIAL COMPLIANCE WITH INHALED NITRIC OXIDE (iNO) TREATMENT
CN120114475A (zh) 吸入性一氧化氮和氧气用于治疗肺高压症的用途
HK40049023A (zh) 脉动式输送一氧化氮的方法和装置
HK40055059A (en) Use of inhaled nitric oxide (ino) for the improvement of severe hypoxemia
JP2025501414A (ja) サルコイドーシスに関連する肺高血圧症(PH-SARC)を有する患者を治療するための一酸化窒素吸入療法(iNO)の使用
HK40049023B (zh) 脉动式输送一氧化氮的方法和装置

Legal Events

Date Code Title Description
HB Alteration of name in register

Owner name: BELLEROPHON THERAPEUTICS, INC.

Free format text: FORMER NAME(S): BELLEROPHON THERAPEUTICS

PC1 Assignment before grant (sect. 113)

Owner name: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED

Free format text: FORMER APPLICANT(S): BELLEROPHON THERAPEUTICS, INC.

FGA Letters patent sealed or granted (standard patent)